JP2020519656A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519656A5
JP2020519656A5 JP2019562657A JP2019562657A JP2020519656A5 JP 2020519656 A5 JP2020519656 A5 JP 2020519656A5 JP 2019562657 A JP2019562657 A JP 2019562657A JP 2019562657 A JP2019562657 A JP 2019562657A JP 2020519656 A5 JP2020519656 A5 JP 2020519656A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
topical pharmaceutical
composition according
tazarotene
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019562657A
Other languages
English (en)
Japanese (ja)
Other versions
JP7410720B2 (ja
JP2020519656A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/032359 external-priority patent/WO2018209262A1/en
Publication of JP2020519656A publication Critical patent/JP2020519656A/ja
Publication of JP2020519656A5 publication Critical patent/JP2020519656A5/ja
Application granted granted Critical
Publication of JP7410720B2 publication Critical patent/JP7410720B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019562657A 2017-05-12 2018-05-11 皮膚疾患を治療するための局所組成物および方法 Active JP7410720B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762505421P 2017-05-12 2017-05-12
US62/505,421 2017-05-12
PCT/US2018/032359 WO2018209262A1 (en) 2017-05-12 2018-05-11 Topical compositions and methods for treating skin diseases

Publications (3)

Publication Number Publication Date
JP2020519656A JP2020519656A (ja) 2020-07-02
JP2020519656A5 true JP2020519656A5 (enExample) 2021-07-26
JP7410720B2 JP7410720B2 (ja) 2024-01-10

Family

ID=62386996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019562657A Active JP7410720B2 (ja) 2017-05-12 2018-05-11 皮膚疾患を治療するための局所組成物および方法

Country Status (8)

Country Link
US (1) US20180360752A1 (enExample)
EP (1) EP3621614B1 (enExample)
JP (1) JP7410720B2 (enExample)
BR (1) BR112019023817A8 (enExample)
CA (1) CA3063371A1 (enExample)
PL (1) PL3621614T3 (enExample)
RS (1) RS67211B1 (enExample)
WO (1) WO2018209262A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CA3267519A1 (en) * 2022-09-16 2024-03-21 Bausch Health Ireland Ltd METHODS FOR TREATING ACNE AND OILY SKIN WITH TAZAROTENE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210041C (zh) * 2003-09-29 2005-07-13 中国医学科学院皮肤病研究所 治疗痤疮的复方外用药物
CN108282998B (zh) * 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物

Similar Documents

Publication Publication Date Title
EA201792559A1 (ru) Фармацевтические композиции для местного применения
JP2016535781A5 (enExample)
AU2017320876B2 (en) Methods and compositions for treating cutaneous fungal infections
JPH0222211A (ja) 老化皮膚を治療するための局所適用可能な製剤
JP2011521948A (ja) 皮膚の炎症および変色のための方法ならびに組成物
TWI794222B (zh) 組成物在製備治療睡眠障礙的藥劑的用途
JP2020519656A5 (enExample)
EA201300314A1 (ru) Композиции и лекарственное средство для лечения глазных болезней, устройство, содержащее композиции и лекарственное средство
WO2023141334A3 (en) Pharmaceutical compositions of mycophenolic acid and/or betamethasone for the treatment of ocular disorders
EP3125865B1 (en) Association of active ingredients for topical use in restructuring altered cutaneous barrier following to cutaneous diseases
HRP20211661T1 (hr) Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti
EP2135622B1 (en) Compositions for providing an analgesic effect to the skin
WO2015100348A8 (en) Keloid reduction using topical allantoin
WO2014047288A3 (en) Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
JP5895244B2 (ja) 機能性化粧水
CL2018003268A1 (es) Ácidos carboxílicos para tratar/prevenir una enfermedad de la piel.
US20230293492A1 (en) Methods and compositions for treating cutaneous fungal infections
RU2011121659A (ru) Депигментирующие местные композиции и их применение
JP6749563B2 (ja) 黄色ブドウ球菌抑制溶液、アトピー性皮膚炎治療液、化粧品、洗浄液及び消毒液
RU2016142678A (ru) Способ лечения и/или предотвращения постугревых рубцов с помощью фиксированной комбинации адапалена или его солей и пероксида бензоила
MX2018013474A (es) Acidos carboxilicos para aplicacion en la primera infancia.
CN120603601A (zh) 用于治疗马拉色菌酵母引起的病状的鳄梨不皂化物
WO2016137516A1 (en) Method and topical composition for the treatment of rosacea and skin erythema using pyrithione zinc
MA42111B1 (fr) Compositions pharmaceutiques topiques
RU2020102673A (ru) Антибактериальная активность галактоолигосахарида и ксилита в дерматологических лечениях